Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon

2020 期刊論文

2020年國際 SCI 論文

編號 篇名 作者 期刊 卷期
1 Independent Risk Factors for Death in Patients Admitted for Asthma Exacerbation in Taiwan Chang YL, Ko HK, Lu MS, Chou CL, Su KC, Hsu CC, Chou KT, Chen TJ, Perng DW, Chou YC

NPJ Prim Care Respir Med

2 Low dose of propranolol treatment is associated with better survival in cirrhotic patients with hepatic encephalopathy Lee PC, Chen YJ, Chou YC, Lee KC, Chen PH, Kao WY, Huang YH, Huo TI, Lin HC, Hou MC, Lee FY, Wu JC, Su CW Eur J Gastroenterol Hepatol 2020;32:365-372
3 Role of the Mitochondrial Stress Response in Human Cancer Progression Wang SF, Chen S, Tseng LM, Lee HC Exp Biol Med 2020;245:861-78
4 Potential Therapeutic Agents Against COVID-19: What We Know So Far Lu CC, Chen MY, Lee WS, Chang YL J Chin Med Assoc 2020;83:534-6
5 ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells Under Glucose Deprivation Chen MC, Hsu LL, Wang SF, Hsu CY, Lee SH, Tseng LM Cells 2020;9:E1598
6 Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Diabetes on Coronavirus-19 Pandemic Chen CF, Chen YT, Chen TH, Chen FY, Yang YP, Wang ML, Huo TI, Chang YL, Tan AC, Lin CC J Chin Med Assoc 2020;83:809-811.
7 The Pharmacological Development of Direct Acting Agents for Emerging Needed Therapy Against SARS-CoV-2 Wang SF, Chen KH, Wang SY, Yarmishyn AA, Lai WY, Lin YY, Wang ML, Chou SJ, Yang YP, Chang YL J Chin Med Assoc 2020;83:712-718.
8 Pharmacological Development of the Potential Adjuvant Therapeutic Agents Against Coronavirus Disease 2019 Chen KH, Wang SF, Wang SY, Yang YP, Wang ML, Chiou SH, Chang YL J Chin Med Assoc 2020;83:817-821.
9 The Efficacy of First-Line Tyrosine Kinase Inhibitors Combined with Co-medications in Asian Patients with EGFR Mutation Non-Small Cell Lung Cancer  Su VYF, Yang KY, Huang TY, Hsu CC, Chen YM, Yen JC, Chou YC, Chang YL, He CH Sci Rep 2020;10:14965
10 Precipitating factors causing hyperbilirubinemia during chronic hepatitis C treatment with paritaprevir/ritonavir, ombitasvir, and dasabuvir Wang YK, Lee WP, Wang YW, Huang YH, Hou MC, Chang YL, Lan KH J Chin Med Assoc 2020;10.1097
11 Changes in the Systemic Expression of Sirtuin-1 and Oxidative Stress after Intravitreal Anti-Vascular Endothelial Growth Factor in Patients with Retinal Vein Occlusion Hwang DK, Chang YL, Lin TC, Peng CH, Chien KH, Tsai CY, Chen SJ, Chen KH, Hsu MY Biomolecules 2020;10:E1414
12 Hematologic Adverse Drug Reactions Leading to Hospitalization among Cancer Patients: A Retrospective Case-Control Study Chiou BL, Ho CC, Yang CC J Chin Med Assoc 2020; 83: 784-790
13 DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells Wang SF, Huang KH, Tseng WC, Lo JF, Li AFY, Fang WL, Chen CF, Yeh TS, Chang YL, Chou YC, Hung HH, Lee HC. Cancers 2020;12:3463
14 Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary Fibrosis Yang SN, Perng DW, Ko HK, Chang YL, Hsu CC, Huang HY, Chung MI


15 Efficacy and Safety of Rituximab in Autoimmune and Microangiopathic Hemolytic Anemia: A Systematic Review and Meta-Analysis Chao SH, Chang YL, Yen JC, Liao HT, Wu TH, Yu CL, Tasi CY, Chou YC Exp Hematol Oncol 2020;9:6


2020年非 SCI 論文






1 改善心跳停止急救復甦後病人之低溫治療給藥流程 翁如潔、張惠娟、林美玲、王斯郁 醫院藥學 2020; 37:1-9
2 人類免疫缺乏病毒治療進展之案例用藥探討 黃聿璿、何沁沁 醫院藥學 2020; 37:10-17
3 纖維肌痛症之治療 黃冠慈、王斯郁 醫院藥學 2020; 37:18-24
4 不孕症之藥物治療 胡晉嘉、蔡涵怡 醫院藥學 2020; 37:25-33
5 缺血性腦中風治療 陳佳慧、周千瀅 醫院藥學 2020; 37:34-39
6 心房顫動之藥物治療 陳柏瑋、王斯郁 醫院藥學 2020; 37:40-52
7 庫欣氏症之藥物治療 林聖凰、許家禎 醫院藥學 2020; 37:53-58
8 簡介老人潛在不適當用藥 王明業、周千瀅 醫院藥學 2020; 37:59-64
9 類風濕性關節炎之治療現況 李簥安、朱佩欣 醫院藥學 2020; 37:65-71
10 淺談良性攝護腺增生之中西醫藥物治療 林益生、周千瀅 醫院藥學 2020; 37:72-78
11 亨丁頓氏舞蹈症治療新藥Deutetrabenazine 黃冠慈、何沁沁 醫院藥學 2020; 37:79-85
12 疑似Timolol眼藥水引起心搏過緩 陳佳慧、陳奇良、李婉詩 醫院藥學 2020; 37:94-99
13 吸入途徑給予Tranexamic acid治療咳血 陳美瑜、蔡涵怡 醫院藥學 2020; 37:100-104
14 疑似重複投予piperacillin/tazobactam引起白血球及血小板快速降低 林于瑄、何沁沁 醫院藥學 2020; 37:105-112
15 氣喘之治療新趨勢 盧孟穗、蔡涵怡 醫院藥學 2020; 37:113-119
16 急性腎盂腎炎之治療 盧志嘉、蔡涵怡 醫院藥學 2020; 37:120-124
17 分化型甲狀腺癌之治療 林聖凰、何沁沁 醫院藥學 2020; 37:125-128
18 新生兒尿素循環障礙疾病之治療 余聲隆、許家禎 醫院藥學 2020; 37:137-141
19 轉移性黑色素瘤之藥品治療新趨勢 施立于、陳奇良、何沁沁 醫院藥學 2020; 37:142-151
20 潛伏性結核用藥與抗反轉錄病毒藥物之藥物交互作用探討 黃聿璿、朱佩欣 醫院藥學 2020; 37:152-160